Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Byron A. Boyce is active.

Publication


Featured researches published by Byron A. Boyce.


Journal of The Chemical Society, Chemical Communications | 1989

Synthesis of a kinetically stable yttrium-90 labelled macrocycle–antibody conjugate

Jonathan P. L. Cox; Karl J. Jankowski; Ritu Kataky; David Parker; Nigel Robert Arnold Beeley; Byron A. Boyce; Michael Anthony William Eaton; Kenneth Millar; Andrew T. Millican; Alice Harrison; Carole Walker

Lysine is a precursor for the synthesis of an aminobutyl C-functionalised tetra-azacyclododecane tetra-acid which has been linked to B72.3 antibody and may be labelled with 90Y to form a kinetically stable complex of potential use in radioimmunotherapy.


Journal of The Chemical Society, Chemical Communications | 1989

Towards tumour imaging with indium-111 labelled macrocycle–antibody conjugates

Andrew S. Craig; Ian M. Helps; Karl J. Jankowski; David Parker; Nigel Robert Arnold Beeley; Byron A. Boyce; Michael Anthony William Eaton; Andrew T. Millican; Kenneth Millar; Alison Phipps; Stephen Keith Rhind; Alice Harrison; Carole Walker

C-Functionalised triazacyclododecane and triazacyclononane triacid macrocycles have been covalently attached to a monoclonal antibody and may be labelled with 111In to form kinetically inert radiolabelled complexes.


Bioorganic & Medicinal Chemistry Letters | 1994

Potent and selective inhibitors of gelatinase-a 1. hydroxamic acid derivatives

John R. Porter; Nigel Robert Arnold Beeley; Byron A. Boyce; Barbara Mason; Andrew T. Millican; Kenneth Millar; Joanna Leonard; J. Richard Morphy; James P. O'Connell

Abstract A series of hydroxamic acid derivatives were prepared. By introducing aromatic substituents at the P1′ and P3′ positions highly potent gelatinase-A inhibitors, which possess a high degree of selectivity over collagenase and stromelysin, were obtained. These inhibitors may be of therapeutic value in the control of tumour metastasis.


Bioorganic & Medicinal Chemistry Letters | 1994

Potent and selective inhibitors of gelatinase-A 2. carboxylic and phosphonic acid derivatives

J. Richard Morphy; Nigel Robert Arnold Beeley; Byron A. Boyce; Joanna Leonard; Barbara Mason; Andrew T. Millican; Kenneth Millar; James P. O'Connell; John R. Porter

Abstract A series of zinc binding groups was introduced into a pseudopeptide sequence containing aromatic groups in the P1′ position in order to obtain selective inhibitors of gelatinase-A. Carboxylic acid and phosphonic acid groups provided the most potent inhibitors


Journal of The Chemical Society-perkin Transactions 1 | 1990

Synthesis of C- and N-functionalised derivatives of 1,4,7-triazacyclononane-1,4,7-triyltriacetic acid (NOTA), 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetrayltetra-acetic acid (DOTA), and diethylenenetriaminepenta-acetic acid (DTPA): bifunctional complexing agents for the derivatisation of antibodies

Jonathan P. L. Cox; Andrew S. Craig; Ian M. Helps; Karl J. Jankowski; David Parker; Michael Anthony William Eaton; Andrew T. Millican; Kenneth Millar; Nigel Robert Arnold Beeley; Byron A. Boyce

Using (2S)-lysine as a precursor, the syntheses of aminobutyl derivatives of 1,4,7-triazacyclononane, 1,4,7,10-tetra-azacyclododecane, and 3-azapentane-1,5-diamine are described. Transformation into their reactive maleimide derivatives is described and alternative strategies for synthesising the title complexing agents involving nitrogen functionalisation are defined.


Journal of The Chemical Society, Chemical Communications | 1984

Heterotopic ligands:synthesis and complexation properties of phosphine-functionalized dipodal macrocycles

Byron A. Boyce; Annick Carroy; Jean-Marie Lehn; David Parker

The synthesis of a series of phosphine-functionalized dipodal macrocycles is described; prior co-ordination of a cation within the macrocyclic cavity regulates the ligand structure aiding fotmation of heterodinuclear complexes.


Synthesis | 1992

Synthesis of new macroclyclic amino-phosphinic acid complexing agents and their C- and P-functionalised derivaties for protein linkage

Christopher J. Broan; Eleanor Cole; Karl J. Jankowski; David Parker; Kanthi Pulukkody; Byron A. Boyce; Nigel Robert Arnold Beeley; Kenneth Millar; Andrew T. Millican


Journal of Pharmaceutical Sciences | 1995

An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A

Surinder K. Chander; Pari Antoniw; Nigel Robert Arnold Beeley; Byron A. Boyce; Thomas Crabbe; Andrew J. P. Docherty; Joanna Leonard; Barbara Mason; Kenneth Millar; Andrew T. Millican; Richard Morphy; Andrew Mountain; James P. O'Connell; John R. Porter; Neville Willmott


ChemInform | 1990

Synthesis of C- and N-Functionalised Derivatives of 1,4,7-Triazacyclononane-1,4,7-triyltriacetic Acid (NOTA), 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayltetraacetic Acid (DOTA), and Diethylenenetriaminepentaacetic Acid (DTPA): Bif

J. P. L. Cox; A. S. Craig; I. M. Helps; K. J. Jankowski; David Parker; M. A. W. Eaton; A. T. Millican; K. Millar; Nigel Robert Arnold Beeley; Byron A. Boyce


Journal of The Chemical Society, Chemical Communications | 1989

Towards tumours imaging with indium-111 labeled macrocycle―antibody conjugates

Andrew S. Craig; Ian M. Helps; Karl J. Jankowski; David Parker; Nigel Robert Arnold Beeley; Byron A. Boyce; Michael Anthony William Eaton; Andrew T. Millican; Kenneth Millar; Alison Phipps; Stephen Keith Rhind; Alice Harrison; Carole Walker

Collaboration


Dive into the Byron A. Boyce's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carole Walker

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge